Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan

NCT00661661 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
487
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer